Liquidia Technologies, Inc. (NASDAQ:LQDA) Given Average Recommendation of “Buy” by Analysts

Liquidia Technologies, Inc. (NASDAQ:LQDA) has been given a consensus recommendation of “Buy” by the nine analysts that are covering the firm, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell rating, six have issued a buy rating and two have given a strong buy rating to the company. The average 1 year price target among brokerages that have issued a report on the stock in the last year is $26.89.

Several equities research analysts have recently commented on the stock. Needham & Company LLC reissued a “buy” rating on shares of Liquidia Technologies in a research report on Monday, June 2nd. Wall Street Zen upgraded Liquidia Technologies from a “sell” rating to a “hold” rating in a research note on Thursday, May 22nd. Wells Fargo & Company increased their price objective on Liquidia Technologies from $23.00 to $25.00 and gave the stock an “overweight” rating in a research note on Thursday, June 12th. Oppenheimer set a $13.00 target price on Liquidia Technologies and gave the company an “underperform” rating in a report on Monday, May 19th. Finally, BTIG Research reiterated a “buy” rating on shares of Liquidia Technologies in a report on Tuesday, May 27th.

Insider Buying and Selling at Liquidia Technologies

In related news, CEO Roger Jeffs sold 20,252 shares of the firm’s stock in a transaction that occurred on Monday, July 14th. The stock was sold at an average price of $14.28, for a total transaction of $289,198.56. Following the transaction, the chief executive officer directly owned 1,038,560 shares in the company, valued at $14,830,636.80. This trade represents a 1.91% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Sarah Krepp sold 2,673 shares of Liquidia Technologies stock in a transaction on Monday, July 14th. The stock was sold at an average price of $14.28, for a total transaction of $38,170.44. Following the completion of the transaction, the insider directly owned 142,499 shares in the company, valued at approximately $2,034,885.72. The trade was a 1.84% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders sold 58,760 shares of company stock valued at $839,750. 30.10% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Liquidia Technologies

Large investors have recently made changes to their positions in the business. Raymond James Financial Inc. purchased a new stake in Liquidia Technologies in the fourth quarter worth $218,000. Teacher Retirement System of Texas grew its position in shares of Liquidia Technologies by 42.0% in the 4th quarter. Teacher Retirement System of Texas now owns 16,322 shares of the company’s stock worth $192,000 after buying an additional 4,825 shares during the period. KLP Kapitalforvaltning AS bought a new position in shares of Liquidia Technologies in the 4th quarter worth about $169,000. Vanguard Group Inc. increased its stake in shares of Liquidia Technologies by 3.4% in the 4th quarter. Vanguard Group Inc. now owns 3,557,296 shares of the company’s stock worth $41,834,000 after acquiring an additional 115,367 shares in the last quarter. Finally, Corebridge Financial Inc. lifted its position in Liquidia Technologies by 2.3% during the 4th quarter. Corebridge Financial Inc. now owns 31,516 shares of the company’s stock valued at $371,000 after acquiring an additional 694 shares during the period. 64.54% of the stock is currently owned by institutional investors.

Liquidia Technologies Price Performance

LQDA stock opened at $19.26 on Wednesday. The company has a quick ratio of 2.91, a current ratio of 2.93 and a debt-to-equity ratio of 2.08. The firm has a market cap of $1.65 billion, a price-to-earnings ratio of -12.19 and a beta of -0.01. The company’s fifty day simple moving average is $14.95 and its 200 day simple moving average is $14.80. Liquidia Technologies has a 12-month low of $8.26 and a 12-month high of $20.13.

Liquidia Technologies (NASDAQ:LQDA) last issued its quarterly earnings results on Thursday, May 8th. The company reported ($0.45) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.42) by ($0.03). The business had revenue of $3.12 million during the quarter, compared to analyst estimates of $3.23 million. Liquidia Technologies had a negative net margin of 903.80% and a negative return on equity of 177.91%. On average, analysts expect that Liquidia Technologies will post -1.51 earnings per share for the current year.

Liquidia Technologies Company Profile

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD).